Benson Hill launches CRISPR 3.0, an alternative genome editing tool


In Missouri, Benson Hill Biosystems, an agricultural technology company that uses cloud biology to unlock the genetic potential of plants, launched CRISPR 3.0, a novel family of Cms1 nucleases as part of its suite of genomics tools to accelerate crop performance improvements.

Matthew Crisp, CEO and co-founder of Benson Hill Biosystems said, “CRISPR 3.0 expands the portfolio of genome editing capabilities we are building for our partners to leverage the natural genetic diversity of plants and develop more nutrient-dense crops, improve crop productivity and use natural resources more efficiently.”

Benson Hill’s CRISPR 3.0 portfolio of nucleases demonstrate a shorter length than many other widely-used nucleases, enabling easier delivery.  With uncertainty around the intellectual property landscape and broad claims surrounding the widely used CRISPR/Cas9, CRISPR 3.0 and Benson Hill’s partnership business model offer an alternative genome editing solution for organizations interested in accessing this powerful technology to accelerate their business goals.